Every now and then, a disruptive company will show up and shake up how a certain industry does things. That’s what’s currently happening in the healthcare world for a certain Toronto-based company, which announced that it has entered into a global distribution and marketing agreement with ASCEND Cardiovascular. According to the release, Ascend’s IT software is used by 50,000 hospitals, clinics and caregivers, and the company will be integrated into Ascend’s IT for cardiovascular care. 

Shares of VentriPoint Diagnostics Ltd. (TSXV:VPT)(OTCQB:VPTDF) rallied strongly after the announcement, with shares on the Canadian side reaching up to $0.29/share (+13.73%) at the early session high. This move is a strong continuation of the success this stock has had over the last month. 

VentriPoint Diagnostics Ltd is a Canada based medical device company. It is primarily engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. The company develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure and normal hearts. It sells its products in Canada and internationally.

Copyright © 2023 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.